Delivery Order SPE2DE24D0021-SPE2D626F80J5
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,750 by the Department of Defense's Medical Supply Chain for SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of March 4, 2026. This award represents a child contract issued under a larger indefinite delivery vehicle and involves no set-aside designation, indicating...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $2.2K on December 4, 2025, for SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract, which carries an ultimate completion date of February 3, 2026, was issued by the Department of Defense's Medical Supply Chain without set-aside designation, indicating open competition. Performance will be fulfilled from Fisher Scientific's principal place of business in Pittsburgh, Pennsylvania. This...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 by the Department of Defense's Medical Supply Chain on December 4, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of February 3, 2026. The award is a child contract under a larger vehicle and required no set-aside designation, indicating open competition. Performance...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,650 for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits by the Department of Defense's Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is effective through January 27, 2026, and represents a child order under Fisher Scientific's existing blanket purchase agreement vehicle. No set-aside designation was applied to this award, indicating open competition. The...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order award valued at $5,500 from the Department of Defense's Medical Supply Chain on October 28, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The delivery order operates as a child contract under a larger procurement vehicle and carries an ultimate completion date of December 26, 2025. The award was made on a competitive basis with no set-aside designation. Performance will be conducted at Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,100 by the Department of Defense's Medical Supply Chain for SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The award, issued on December 9, 2025, is a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of February 6, 2026. The contract is a child order under a larger vehicle, with performance taking place at Fisher Scientific's location in Pittsburgh,...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $11,000 for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract, awarded January 7, 2026, with an ultimate completion date of March 6, 2026, was issued by the Department of Defense's Medical Supply Chain without a set-aside designation, indicating open competition. The work will be performed in Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal place of...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,300 for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits under a contract with the Department of Defense's Medical Supply Chain. The award, issued on December 8, 2025, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of February 5, 2026. This delivery order represents a child contract with no set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300 on January 6, 2026, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment provisions. The award, issued by the Department of Defense's Medical Supply Chain, is scheduled for completion by March 5, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger vehicle and was awarded without...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,300 for the supply of SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment. The award, issued on December 3, 2025, with an ultimate completion date of February 2, 2026, was made by the Department of Defense's Medical Supply Chain. Performance will occur in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F80J5Delivery Order
Fisher Scientific Company L.L.C. received a delivery order award (4570407195) from the Department of Defense's Medical Supply Chain on January 6, 2026, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract carries a ceiling value of $5,500 and is structured as a fixed-price delivery order with economic price adjustment provisions. Performance will be completed by March 5, 2026, at Fisher Scientific's principal place of business in Pittsburgh, Pennsylvania. This award was made without set-aside designation, indicating competitive procurement in an open federal environment. This delivery order represents a child contract under a larger indefinite delivery vehicle or multiple award schedule arrangement, reflecting Fisher Scientific's established position as a critical supplier of laboratory and diagnostic equipment to the Department of Defense. Fisher Scientific's substantial federal contract portfolio demonstrates its extensive capabilities in providing specialized diagnostic test kits, laboratory equipment, and medical supplies to defense and civilian agencies, including the Department of Veterans Affairs and the National Institutes of Health. The company's proven track record of reliable delivery on healthcare and diagnostic procurement supports its selection for this infectious disease testing requirement, which aligns with the Medical Supply Chain's mission to provide medical products and supplies supporting military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 1/5/26 |